Literature DB >> 29524051

Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.

Li Lin1, Li Juan Zheng1, Long Jiang Zhang2.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease that develops insidiously and causes dementia finally. There are also clinical complications in advanced dementia, such as eating problems, infections, which will lead to the decline of patients' life quality, and the rising cost of care for AD to our society. AD will be important public health challenge. Early detection of AD may be a key issue to prevent, delay, and stop the disease. Gut microbiome and neuroinflammation are closely related with nervous system diseases, although the specific mechanism is not clear. This review introduces the relationship between neuroinflammation, gut microbiome, and AD.

Entities:  

Keywords:  Alzheimer’s disease; Gut microbiome; Neuroinflammation

Mesh:

Year:  2018        PMID: 29524051     DOI: 10.1007/s12035-018-0983-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  95 in total

Review 1.  Signals for the induction of nitric oxide synthase in astrocytes.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Neurochem Int       Date:  2006-06-05       Impact factor: 3.921

2.  Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Authors:  Bruno P Imbimbo; Vincenzo Solfrizzi; Francesco Panza
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

3.  Consumption of fermented milk product with probiotic modulates brain activity.

Authors:  Kirsten Tillisch; Jennifer Labus; Lisa Kilpatrick; Zhiguo Jiang; Jean Stains; Bahar Ebrat; Denis Guyonnet; Sophie Legrain-Raspaud; Beatrice Trotin; Bruce Naliboff; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

Review 4.  Schizophrenia and the gut-brain axis.

Authors:  Katlyn Nemani; Reza Hosseini Ghomi; Beth McCormick; Xiaoduo Fan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-09-19       Impact factor: 5.067

5.  Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome.

Authors:  Christina L Ohland; Lisa Kish; Haley Bell; Aducio Thiesen; Naomi Hotte; Evelina Pankiv; Karen L Madsen
Journal:  Psychoneuroendocrinology       Date:  2013-04-06       Impact factor: 4.905

Review 6.  The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.

Authors:  Myles R Minter; Juliet M Taylor; Peter J Crack
Journal:  J Neurochem       Date:  2015-11-18       Impact factor: 5.372

Review 7.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

Review 8.  Noninvasive molecular imaging of neuroinflammation.

Authors:  Andreas H Jacobs; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-02       Impact factor: 6.200

9.  Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation.

Authors:  Chenggui Wang; Qingqing Wang; Yiting Lou; Jianxiang Xu; Zhenhua Feng; Yu Chen; Qian Tang; Gang Zheng; Zengjie Zhang; Yaosen Wu; Naifeng Tian; Yifei Zhou; Huazi Xu; Xiaolei Zhang
Journal:  J Cell Mol Med       Date:  2017-11-17       Impact factor: 5.310

Review 10.  Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer's disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms.

Authors:  Angela Trovato Salinaro; Manuela Pennisi; Rosanna Di Paola; Vittorio Calabrese; Maria Scuto; Rosalia Crupi; Maria Teresa Cambria; Maria Laura Ontario; Mario Tomasello; Maurizio Uva; Luigi Maiolino; Edward J Calabrese; Salvatore Cuzzocrea
Journal:  Immun Ageing       Date:  2018-02-14       Impact factor: 6.400

View more
  22 in total

1.  Genome-wide transcriptomic analysis of microglia reveals impaired responses in aged mice after cerebral ischemia.

Authors:  Ligen Shi; Marcelo Rocha; Wenting Zhang; Ming Jiang; Sicheng Li; Qing Ye; Sulaiman H Hassan; Liqiang Liu; Maya N Adair; Jing Xu; Jianhua Luo; Xiaoming Hu; Lawrence R Wechsler; Jun Chen; Yejie Shi
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-21       Impact factor: 6.200

Review 2.  Autophagy Balances Neuroinflammation in Alzheimer's Disease.

Authors:  Xuehua Cheng; Yong Wei; Zijun Qian; Li Han
Journal:  Cell Mol Neurobiol       Date:  2022-08-12       Impact factor: 4.231

Review 3.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

Review 4.  Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.

Authors:  Priyanka Nagu; Arun Parashar; Tapan Behl; Vineet Mehta
Journal:  J Mol Neurosci       Date:  2021-04-08       Impact factor: 3.444

Review 5.  Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction.

Authors:  Justin Cho; You Jeong Park; Bella Gonzales-Portillo; Madeline Saft; Blaise Cozene; Nadia Sadanandan; Cesar V Borlongan
Journal:  CNS Neurosci Ther       Date:  2021-01-19       Impact factor: 5.243

Review 6.  Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment.

Authors:  Alexander Popescu; Monica German
Journal:  Nutrients       Date:  2021-06-27       Impact factor: 5.717

7.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

Review 8.  Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.

Authors:  Vo Van Giau; Si Ying Wu; Angelo Jamerlan; Seong Soo A An; Sang Yun Kim; John Hulme
Journal:  Nutrients       Date:  2018-11-14       Impact factor: 5.717

Review 9.  Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis.

Authors:  Enrico Patrono; Jan Svoboda; Aleš Stuchlík
Journal:  Behav Brain Funct       Date:  2021-06-22       Impact factor: 3.759

Review 10.  Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins.

Authors:  Muhammad Sohail Khan; Muhammad Ikram; Jun Sung Park; Tae Ju Park; Myeong Ok Kim
Journal:  Cells       Date:  2020-04-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.